2018 ACR/ARHP Annual Meeting

October 19-24, 2018. Chicago, IL.

View by Number View by Title View Sessions

View by Date

Jump to: View All • a b c d e [f] g h i j k l m n o p q r s t u v w x y z

Abstract Number: 2366

Facilitating Shared Decision Making in Psoriatic Arthritis: Factors Influencing Patient Preference for Treatment Mode of Administration
Abstract Number: 298

Factors Affecting Inpatient Mortality in Hospitalizations for Sepsis with Underlying Systemic Lupus Erythematosus: Data from the National Inpatient Sample 2010-2014
Abstract Number: 2285

Factors Associated with Corticosteroid Discontinuation, Complete Clinical Response and Remission in Patients with Juvenile Dermatomyositis
Abstract Number: 1801

Factors Associated with Damage Progression in Behçet’s Syndrome Uveitis
Abstract Number: 1478

Factors Associated with Disability and Health-Related Quality of Life in Biologic-Treated Patients with Rheumatoid Arthritis in Persistent Moderate Disease Activity
Abstract Number: 246

Factors Associated with Disability in a Prospective Cohort of Complex Regional Pain Syndrome Type 1
Abstract Number: 291

Factors Associated with High-Dose Corticosteroid Use in SLE Patients Post Initiation of SLE Therapy
Abstract Number: 1954

Factors Associated with Overweight or Obesity in Athletes 5 Years after Anterior Cruciate Ligament Injury
Abstract Number: 1396

Factors Associated with Specific Quality of Life Evolution in SLE Patients: A French Prospective Longitudinal Multicenter Study
Abstract Number: 520

Factors Associated with the Developement of Severe Respiratory Infections in Patients with Rheumatoid Arthritis Included in a Vaccination Program
Abstract Number: 1133

Factors for Opioids Use in the Early Treatment Options for the Knee Osteoarthritis Patients
Abstract Number: 2717

Factors Predicting Severe Infections in Patients with Systemic Necrotizing Vasculitides Based on Data from 733 Patients Enrolled in Randomized–Controlled Trials
Abstract Number: 1777

Factors Related to Deterioration of IgG4-Related Disease in Untreated Patients with IgG4-Related Disease
Abstract Number: 2954

Factors Related to Initiation of TNF Inhibitor Versus Triple Therapy in Rheumatoid Arthritis Patients
Abstract Number: 1661

Factors That May be Associated with Uveitis in Patients with Spondyloarthritis
Abstract Number: 869

Failure to Reach Serum Urate Target Is Associated with Elevated Mortality in Gout
Abstract Number: 2442

Familial Mediterranean Fever Associated Infertility and Underlying Factors with Fertility
Abstract Number: 1319

Familial Mediterranean Fever Related Damage Assessed By Auto-Inflammatory Disease Damage Index (ADDI) and Associated Factors with Damage
Abstract Number: 1159

Fat Mass Is Associated with Musculoskeletal Pain in Women : A Three-Year Longitudinal Study
Abstract Number: 1393

Fatigue in Men and Women with Psoriatic Arthritis: An International Qualitative Study
Abstract Number: 1387

Fatigue in Patients with Rheumatoid Arthritis As Compared to Different Groups of Cancer Patients
Abstract Number: 2552

Fatigue in Psoriatic Arthritis Patients Treated with Intravenous Golimumab: Early Improvement Is Associated with Week 24 Outcomes in Acr 20, 50, and Health-Related Quality of Life
Abstract Number: 1664

Fatigue Measurements in Systemic Lupus Erythematosus
Abstract Number: 2925

Fatty Lesions Detected on MRI Scans in Patients with Ankylosing Spondylitis Are Based on the Deposition of Fat in the Vertebral Bone Marrow
Abstract Number: 1548

Favorable Effect of Hydroxychloroquine in Patients with Rheumatoid Arthritis and Diabetes or Impaired Glucose Control
Abstract Number: 2743

Favorable Efficacy of Rituximab in ANCA-Associated Vasculitis Patients with Excessive B Cell Differentiation
Abstract Number: 1786

Favourable Response to Rituximab for the Treatment of IgG4-Related Disease: Long-Term Follow-up of 10 Patients Resistant to Glucocorticoids and Immunosuppressives
Abstract Number: 2212

Feasibility and Performance of HR-pQCT-Derived Joint Space Width Measurement As Outcome Parameter in Arthropathic Disease – Lessons from Hemochromatosis Arthropathy
Abstract Number: 405

Feasibility of Enabling Self-Management and Coping with Arthritic Pain Using Exercise (ESCAPE-Pain) Programme for Knee Osteoarthritis in Malaysia
Abstract Number: 2493

Features of Disease Severity Associated with Patient Satisfaction with Biologic Treatment: Results from the Abatacept Best Care Real-World Study
Abstract Number: 452

Features of Peripheral and Central Sensitization and Neuropathic Pain Are Seen in Both Osteoarthritis and Rheumatoid Arthritis
Abstract Number: 1725

Fecal Microbiota Transplantation in Patients with Systemic Sclerosis- a Pilot Study
Abstract Number: 1900

FGFR3/ FGF9 Regulates the Activity of Profibrotic Cytokine and Growth Factor Pathways to Drive Fibroblast Activation and Tissue Fibrosis in Systemic Sclerosis
Abstract Number: 1462

Fibrin Deposition and Neutrophil Infiltration of Rheumatoid Arthritis Synovium Are Associated with Duration of Morning Stiffness
Abstract Number: 1072

Fibrin-Triggered Chondrosynovial Adhesion As a Novel Mechanism of Cartilage Damage in Rheumatoid Arthritis
Abstract Number: 10

Fibroblast like Synoviocytes (FLS) Are Capable of Inducing Phenotypical Changes Including Class Switch Recombination (CSR) in Naive B Cells, but Additional Factors Are Required to Trigger Immunoglobulin Secretion
Abstract Number: 1029

Fibroblast-like Synoviocytes As Immune Effectors in the Pathogenesis of Synovial Lesion in Antibiotic-Refractory Lyme Arthritis
Abstract Number: 2025

Fibroblast-like Synoviocytes from Juvenile Idiopathic Arthritis and Controls Influence Expression of Bone Morphogenetic Protein Antagonists in Chondrocytes
Abstract Number: 932

Fibroblasts Senescence Is Observed in Rheumatoid and Osteoarthritic Synovial Tissues and Triggers a Pro-Inflammatory Program Ex Vivo
Abstract Number: 1836

Fibromyalgia Diagnosis and Biased Assessment: Sex, Prevalence, Biology and Bias
Abstract Number: 839

Fibromyalgia Is Identified in Routine Care on Indices Derived from an MDHAQ (MultiDimensional Health Assessment Questionnaire) with Robust Agreement with 2011 Revised Fibromyalgia Criteria Questionnaire
Abstract Number: 253

Fibromyalgia Patients Are Frequently Thought to be Challenging to Treat-Are They?
Abstract Number: 250

Fibromyalgia Patients Do Not Appear to Obsess about Their Symptoms Compared with Other Rheumatic Disease Patients
Abstract Number: 247

Fibromyalgia Patients Often Receive Several Rheumatic Disease Diagnoses
Abstract Number: 1838

Fibromyalgia, Beyond the 2016 Establishment. an Analysis of Novel Symptom Clusters for Differentiating Fibromyalgia from Other Chronic Pain Disorders
Abstract Number: 1821

Filgotinib, an Oral, Selective Janus Kinase 1 Inhibitor, Is Effective in Psoriatic Arthritis Patients with an Inadequate Response to Conventional Disease-Modifying Anti-Rheumatic Drugs: Results from a Randomized, Placebo-Controlled, Phase 2 Study
Abstract Number: 1201

Finger Extensor Tendon Involvement Is Frequent in Early Rheumatoid Arthritis
Abstract Number: 854

First and Recurrent Thrombosis Risk after 1897 Patient-Years of Follow-up: Prospective Results from Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository (“Registry”)
Abstract Number: 657

First Validation of Consensus Definitions for MRI Lesions in the Sacroiliac Joint By the Assessments in Spondyloarthritis International Society MRI Group
Abstract Number: 686

Five-Year Efficacy and Safety of Apremilast Treatment in Subjects with Psa: A Pooled Analysis of the 3 Phase III Studies
Abstract Number: 1816

Five-Year Outcome of Operative and Nonoperative Management of Meniscal Tear in the Presence of Osteoarthritic Changes
Abstract Number: 2374

Flare Warnings: People with Rheumatoid Arthritis’ Perceptions of Their Flares
Abstract Number: 1357

Flexion Contractures Are Associated with Worse Pain, Stiffness, and Function in Patients with Knee Osteoarthritis
Abstract Number: 171

Flow Cytometric Assessment of the Mammalian Target of Rapamycin Pathway Using Antiphospholipid Syndrome As a Disease Model
Abstract Number: 2209

Fluorescence Optical Imaging Xiralite® Is Helpful in the Decision for Rituximab Re-Therapy in Patients with Rheumatoid Arthritis
Abstract Number: 2846

Foot and Lower Limb Characteristics in People with SLE: A Comparison with Age- and Sex-Matched Healthy Control Participants
Abstract Number: 1240

Foot Osteomyelitis in Inflammatory Rheumatic Diseases: A Retrospective Observational Study
Abstract Number: 2302

Forearm Bone Mineral Density and Fracture Incidence in Postmenopausal Women with Osteoporosis
Abstract Number: 2810

Fracture and Bone Mineral Density Response By Baseline Risk in Patients Treated with Abaloparatide Followed By Alendronate
Abstract Number: 2318

Fracture Liaison Service in an Open Health System: Outcomes and Challenges
Abstract Number: 1633

Fragility Fractures in Psoriatic Arthritis Patients: A Matched-Control Study
Abstract Number: 1703

Fragmented Qrs in Patients with Systemic Lupus Erythematosus: Relation to the Disease Activity: A Cross-Sectional Study
Abstract Number: 795

Frequency and Clinical Associations of Rare Antibodies in a Large Connective Tissue Disease Cohort
Abstract Number: 1537

Frequency and Duration of Early Non-Serious Adverse Events in Rheumatoid Arthritis Patients Treated with Tofacitinib 5 Mg Twice Daily As Monotherapy and Combination Therapy
Abstract Number: 1592

Frequency and Pattern of the Uveitis in Spondyloarthritis with Biological Therapy
Abstract Number: 1636

Frequency and Specificity of MRI Lesions in the Sacroiliac Joints of Patients with Axial Spondyloarthritis and Non-Specific Back Pain: First Analysis of MRI Scans from the Assessments in Spondyloarthritis International Society Classification Cohort
Abstract Number: 1166

Friend or Foe: Does Walking at Higher Intensities Increase or Decrease the Risk of Total Knee Arthroplasty over Five Years?
Abstract Number: 2733

From a Myth to a Menace: Increased Disease Severity and Poor Outcomes in an Urban Cohort of African-American Patients with ANCA-Associated Vasculitis
Abstract Number: 1826

From Cancer to Autoimmunity : A New Model of Rheumatoid Arthritis Emerging from a Constitutional Genetic Approach Used in Low Penetrance Cancers
Abstract Number: 986

Fucosylated Tumor Necrosis Factor α Is Expressed in Rheumatoid Arthritis Synovial Tissues and Is Involved in Monocyte Adhesion
Abstract Number: 1336

Functional, Radiographic and Serologic Correlates of Anti-SSA52 Kd – Associated Interstitial Lung Disease
Abstract Number: 1760

Fungal Composition of the Nasal Mucosa in Patients with Granulomatosis with Polyangiitis

Jump to: View All • a b c d e [f] g h i j k l m n o p q r s t u v w x y z

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].